Home / GLP-1 appeals / Mounjaro / Medicaid

Mounjaro denial · Medicaid

Medicaid denied your Mounjaro. Here is how to appeal it.

Most Medicaid managed-care GLP-1 denials are winnable, if your appeal speaks to your plan's own policy and the criteria that apply in your state, and lands before the deadline. We draft it for free, grounded in your Medicaid plan's actual coverage rules with every citation verified. You review, sign, and file it.

Check my Medicaid denial, free See the strategy

Free to draft. Every citation checked against your Medicaid plan's policy before you file.

Your deadline

Often 60 days

Medicaid managed-care plans generally give you 60 days from the adverse benefit determination notice to start an internal appeal, and some states allow longer. You can appeal in writing or by phone. Your notice controls, check it.

Most common reason

Read as off-label weight loss

For a type 2 diabetes prescription, the plan often denies as if it were for weight loss, or requires a documented trial of metformin first. Federal data put the overall Medicaid prior-authorization denial rate near 12.5 percent (HHS OIG, 2023).

What wins

Criteria + fair hearing

Document the type 2 diabetes diagnosis and map your records to the exact criterion the plan cited. If the plan mishandles notice or timing, you may be deemed to have exhausted and can request a state fair hearing.

Why Medicaid denies Mounjaro

Mounjaro (tirzepatide) is FDA-approved for type 2 diabetes. Medicaid managed-care plans cover it under the pharmacy benefit, but behind prior authorization, a preferred drug list, and step therapy. Denials usually come down to a handful of patterns:

  • Read as off-label for weight loss. This is the most common driver for a diabetes drug. If the diagnosis on the claim is not clearly type 2 diabetes, the plan can treat the prescription as off-label for weight loss and deny it, even when it was prescribed for diabetes.
  • Step therapy or preferred drug list. Medicaid managed care commonly requires a documented trial and failure of preferred agents first, typically metformin, before a GLP-1. If your records do not show that trial and failure, the claim is denied even when the trial happened.
  • Medical necessity not met under the plan's criteria. The plan applies MCG, InterQual, or proprietary criteria, often more strictly than published standards. A denial frequently means the submitted records did not show the specific diagnosis, lab values, or prior-therapy criterion the plan requires.
  • No prior authorization on file. Medicaid managed care uses prior authorization extensively. A missing, expired, or mismatched authorization can stop the claim before a clinical reviewer looks at it.

How to win the appeal with Medicaid

The pattern that works against a Medicaid managed-care plan is precision: document the diabetes diagnosis, match the exact criteria the plan cited, then use the Medicaid appeal rights built into federal law.

The move: request the exact MCG, InterQual, or proprietary criterion the plan applied, then show, line by line, where your records meet each point. Lead with documentation that Mounjaro was prescribed for type 2 diabetes, which directly answers the off-label-for-weight-loss read. Appeals that answer the specific criterion the plan cited consistently outperform generic letters.

  • Document the type 2 diabetes diagnosis. Attach the diagnosis, relevant lab values, and the prescriber's note so the plan cannot treat the prescription as off-label for weight loss.
  • Answer the step-therapy and preferred-drug-list requirement. Document the trial and failure or intolerance of metformin and any other preferred agent the plan requires, with dates.
  • File the internal appeal within the window. A Medicaid managed-care plan generally gives you 60 days from the adverse benefit determination notice, and you may request the appeal orally or in writing. File before the action's effective date and your benefits can continue during the appeal in many cases. For an enrollee under 21, the EPSDT mandate (42 USC 1396d(r)) requires coverage of any medically necessary service.
  • Use deemed exhaustion when the plan mishandles the process. Under 42 CFR 438.402(c)(1)(i), if the plan fails to meet notice and timing requirements, you are deemed to have exhausted the internal appeal and may request a state fair hearing directly.

Sources include your Medicaid plan's published coverage policy, the medical-necessity criteria that apply in your state, and the Mounjaro prescribing information. We cite the specific policy that applies to your plan when we build your appeal.

The magic is visible

Your appeal, built from your Medicaid plan's own rules. Every citation checked.

We draft from the sources below, then verify each one before you file. On our held-out testing: 0 invented citations, versus about 1 in 4 for raw AI.

  • Your Medicaid plan's coverage policyYour Medicaid plan's published coverage policy and the medical-necessity criteria that apply in your stateVerified
  • FDA labelTirzepatide (Mounjaro) prescribing information, indication and dosingVerified
  • Your recordsYour type 2 diabetes diagnosis, lab values, and prior therapies, cited back accuratelyVerified

Let's check your Medicaid denial, free.

Answer a few questions for an honest read on your odds, then your verified draft. No account, no cost.

Check my denial, free

Medicaid + Mounjaro: common questions

How long do I have to appeal?
Medicaid managed-care plans generally give you 60 calendar days from the date on the adverse benefit determination notice to request an internal appeal, and some states allow longer. You can appeal in writing or by phone. After the internal appeal you can request a state fair hearing. Your notice states the deadline that applies to you, and that controls. File as early as you can.
Do I need my doctor to appeal?
You can file the appeal yourself. A strong appeal often includes a letter of medical necessity from your prescriber confirming the type 2 diabetes diagnosis, but the administrative appeal is your right to submit. If a fresh clinical opinion is needed, that comes from a licensed clinician, not from us.
It was denied as off-label. Can I still appeal?
Yes. If Mounjaro was prescribed for type 2 diabetes, the appeal should document that diagnosis directly, since the off-label-for-weight-loss read often rests on a missing or unclear diagnosis on the claim. For an enrollee under 21, the EPSDT mandate can require coverage of a medically necessary service. We will tell you honestly if a denial is not worth appealing.
Is this really free?
Yes. We draft your appeal for free and you file it. No fee, no contingency, nothing taken from coverage you win. AppealIt is not a law firm and does not provide legal or medical advice.

Other Mounjaro appeals: UnitedHealthcare · Aetna · Cigna · All Mounjaro denials